Timár Orsolya, Soltész Pál, Szamosi Szilvia, Dér Henrietta, Szántó Sándor, Szekanecz Zoltán, Szücs Gabriella
Third Department of Medicine, Cardiovascular Unit and Rheumatology Division, University of Debrecen Medical Center, Debrecen, Hungary.
J Rheumatol. 2008 Jul;35(7):1329-33. Epub 2008 May 15.
Endothelial dysfunction and vasculopathy of the small and large vessels are crucial pathogenic factors in systemic sclerosis (SSc). Accelerated atherosclerosis and impaired flow-mediated vasodilation have been described in SSc. We evaluated arterial stiffness in patients with SSc compared to healthy controls.
Augmentation index (AI) and pulse wave velocity (PWV) of the brachial artery were measured in 40 patients with SSc and 35 age and sex matched healthy controls using an arteriograph system.
AI was significantly higher in SSc patients (9.02) compared to controls (-41.15) (p < 0.0001). PWV was similarly higher in patients with SSc (9.67 m/s) than in controls (8.00 m/s) (p = 0.0017). PWV was significantly higher in patients with localized SSc (10.04 +/- 2.01 m/s) compared to those with diffuse SSc (8.39 +/- 1.87 m/s) (p = 0.034). There was a significant, positive linear correlation between AI and PWV (r = 0.32, p = 0.045). We also observed significant correlations between AI and age (r = 0.31, p = 0.048), PWV and age (r = 0.36, p = 0.021), and PWV and disease duration (r = 0.40, p = 0.011) in SSc patients.
Increased AI and PWV of the aorta in comparison to age and sex matched healthy controls indicate increased large-vessel stiffness in patients with SSc. PWV and AI are reproducible indicators of the presence and degree of arterial stiffening. Because arterial stiffness may correlate with disease duration and age in patients with SSc, it may be a useful diagnostic test in the assessment of arterial function. Increased vascular stiffness may be therapeutically targeted by statins and other vasoprotective agents during the management of SSc.
小血管和大血管的内皮功能障碍及血管病变是系统性硬化症(SSc)的关键致病因素。已有研究描述了SSc患者存在动脉粥样硬化加速和血流介导的血管舒张受损的情况。我们比较了SSc患者与健康对照者的动脉僵硬度。
使用动脉造影系统对40例SSc患者和35例年龄及性别匹配的健康对照者测量肱动脉的增强指数(AI)和脉搏波速度(PWV)。
与对照组(-41.15)相比,SSc患者的AI显著更高(9.02)(p < 0.0001)。SSc患者的PWV同样高于对照组(8.00 m/s)(9.67 m/s)(p = 0.0017)。与弥漫性SSc患者(8.39 +/- 1.87 m/s)相比,局限性SSc患者的PWV显著更高(10.04 +/- 2.01 m/s)(p = 0.034)。AI与PWV之间存在显著的正线性相关(r = 0.32,p = 0.045)。我们还观察到SSc患者中AI与年龄(r = 0.31,p = 0.048)、PWV与年龄(r = 0.36,p = 0.021)以及PWV与病程(r = 0.40,p = 0.011)之间存在显著相关性。
与年龄及性别匹配的健康对照者相比,SSc患者主动脉的AI和PWV升高表明大血管僵硬度增加。PWV和AI是动脉僵硬度存在及程度的可重复性指标。由于动脉僵硬度可能与SSc患者的病程和年龄相关,它可能是评估动脉功能的一项有用诊断测试。在SSc的治疗过程中,他汀类药物和其他血管保护剂可能针对血管僵硬度增加进行治疗。